Contribution of Real-World Evidence for the Orphan Medicines Approvals in the European Union Between 2000 and 2025
- DOI
- 10.1007/s43441-026-01044-5
- Published
- 2026-09-09
- Container
- Therapeutic Innovation & Regulatory Science
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s43441-026-01044-5,
title = {Contribution of Real-World Evidence for the Orphan Medicines Approvals in the European Union Between 2000 and 2025},
author = {Luísa Bouwman and Diogo Almeida and Carla Jonker and Hubert Leufkens and Bruno Sepodes and Carla Torre},
year = {2026},
journal = {Therapeutic Innovation \& Regulatory Science},
doi = {10.1007/s43441-026-01044-5},
url = {https://doi.org/10.1007/s43441-026-01044-5}
}RIS
TY - JOUR TI - Contribution of Real-World Evidence for the Orphan Medicines Approvals in the European Union Between 2000 and 2025 AU - Luísa Bouwman AU - Diogo Almeida AU - Carla Jonker AU - Hubert Leufkens AU - Bruno Sepodes AU - Carla Torre PY - 2026 JO - Therapeutic Innovation & Regulatory Science DO - 10.1007/s43441-026-01044-5 UR - https://doi.org/10.1007/s43441-026-01044-5 ER -
APA
Bouwman, L., Almeida, D., Jonker, C., Leufkens, H., Sepodes, B., & Torre, C. (2026). Contribution of Real-World Evidence for the Orphan Medicines Approvals in the European Union Between 2000 and 2025. Therapeutic Innovation & Regulatory Science. https://doi.org/10.1007/s43441-026-01044-5
Source records
- crossref · retrieved 2026-11-10T20:42:03.040Z